6212 Federal Register / Vol. 75, No. 25 / Monday, February 8, 2010 / Notices 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services (HHS), is 

contemplating the grant of a an 

exclusive license to practice the 

following invention as embodied in the 

following patent applications: 

(1) E–120–2001/0, Whitehead et al., 

‘‘Development of Mutations Useful for 

Attenuating Dengue Viruses and 

Chimeric Dengue Viruses’’—European 

Patent Application Number 02739358.6, 

filed May 22, 2002; United States Patent 

Application Number 10/719,547, filed 

November 21, 2003, now U.S. Patent 

Number 7,226,602, issued June 5, 2007; 

Canadian Patent Application Number 

2448329, filed May 22, 2002; Australian 

Patent Application Number 

2002312011, filed May 22, 2002, now 

Australian Patent Number 2002312011, 

issued August 8, 2007; Brazilian Patent 

Application Number PI0209943.8, filed 

May 22, 2002; Indian Patent Application 

Number 2184/DELNP/2003, filed May 

22, 2002, now Indian Patent Number 

218306, issued March 31, 2007; Indian 

Patent Application Number 165/ 

DELNP/2008, filed May 22, 2002; 

United States Patent Application 

Number 11/446,050, filed June 2, 2006, 

now U.S. Patent Number 7,560,118, 

issued July 14, 2009; Australian Patent 

Application Number 2008203275, filed 

May 22, 2002; Indian Patent Application 

Number 204/DELNP/2005, filed May 22, 

2002; and United States Patent 

Application Number 12/396,376, filed 

March 2, 2009 

(2) E–089–2002/0,1, Whitehead et al., 

‘‘Dengue Tetravalent Vaccine Containing 

a Common 30 Nucleotide Deletion in 

the 3′-UTR of Dengue Types 1,2,3, and 

4, or Antigenic Chimeric Dengue 

Viruses 1,2,3, and 4’’—United States 

Patent Application Number 10/970,640, 

filed October 21, 2004, now United 

States Patent Number 7,517,531, issued 

April 14, 2009; Canadian Patent 

Application Number 2483653, filed 

April 25, 2003; European Patent 

Application Number 03724319.3, filed 

April 25, 2003; Japanese Patent 

Application Number 2004–50077, filed 

April 25, 2003; Indian Patent 

Application Number 3450/DELNP/2004, 

filed April 25, 2003, now Indian Patent 

Number 3450/DELNP, issued May 29, 

2006; Australian Patent Application 

2003231185, filed April 25, 2003, now 

Australian Patent Number 2003231185, 

issued January 10, 2008; United States 

Patent Application Number 12/398,043, 

filed March 4, 2009; and Brazilian 

Patent Application PI0309631–9, filed 

April 25, 2003 

(3) E–139–2006/0, Whitehead et al., 

‘‘Development of Dengue Vaccine 

Components’’—Australian Patent 

Application 2007285929, filed August 

15, 2007; Canadian Patent Application 

Number 2661296, filed August 15, 2007; 

Chinese Patent Application Number 

200780031489.4, filed August 15, 2007; 

European Patent Application Number 

07840969.5, filed August 15, 2007; 

Indian Patent Application Number 

1608/DELNP/2009, filed August 15, 

2007; United States Patent Application 

Number 12/376,756, filed February 6, 

2009; and Brazilian Patent Application 

TBA, filed August 15, 2007 to 

GlaxoSmithKline Biologicals, having a 

place of business in Rixensart, Belgium. 

The patent rights in this invention have 

been assigned to the United States of 

America. 

DATES: Only written comments and/or 

application for a license which are 

received by the NIH Office of 

Technology Transfer on or before March 

10, 2010 will be considered. 

ADDRESSES: Requests for a copy of the 

patent application, inquiries, comments 

and other materials relating to the 

contemplated license should be directed 

to: Peter Soukas, Office of Technology 

Transfer, National Institutes of Health, 

6011 Executive Boulevard, Suite 325, 

Rockville, MD 20852–3804; E-mail: 

ps193c@nih.gov; Telephone: (301) 435– 

4646; Facsimile: (301) 402–0220. 

SUPPLEMENTARY INFORMATION: The global 

prevalence of dengue has grown 

dramatically in recent decades. The 

disease is now endemic in more than 

100 countries in Africa, North and 

South America, the Eastern 

Mediterranean, Southeast Asia and the 

Western Pacific. Southeast Asia and the 

Western Pacific are most seriously 

affected. Before 1970 only nine 

countries had experienced Dengue 

Hemorrhagic Fever (DHF) epidemics, a 

number that had increased more than 

four-fold by 1995. WHO currently 

estimates there may be 50 million cases 

of dengue infection worldwide every 

year. 

The methods and compositions of this 

invention provide a means for 

prevention of dengue infection and 

dengue hemorrhagic fever (DHF) by 

immunization with attenuated, 

immunogenic viral vaccines against 

dengue. The vaccine is further described 

in Blaney JE et al., ‘‘Mutations which 

enhance the replication of dengue virus 

type 4 and an antigenic chimeric dengue 

virus type 2/4 vaccine candidate in Vero 

cells.’’ Vaccine. 2003 Oct 1;21(27– 

30):4317–27 and Whitehead SS et al., ‘‘A 

live, attenuated dengue virus type 1 

vaccine candidate with a 30-nucleotide 

deletion in the 3′ untranslated region is 

highly attenuated and immunogenic in 

monkeys.’’ J. Virol. 2003 Jan;77(2):1653– 

7. 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. The prospective 

exclusive license may be granted unless, 

within thirty (30) days from the date of 

this published Notice, NIH receives 

written evidence and argument that 

establishes that the grant of the license 

would not be consistent with the 

requirements of 35 U.S.C. 209 and 37 

CFR 404.7. 

The field of use may be limited to 

purified inactivated vaccines against 

dengue infections in humans. 

Properly filed competing applications 

for a license filed in response to this 

notice will be treated as objections to 

the contemplated license. Comments 

and objections submitted in response to 

this notice will not be made available 

for public inspection, and, to the extent 

permitted by law, will not be released 

under the Freedom of Information Act, 

5 U.S.C. 552. 

Dated: January 28, 2010. 

Richard U. Rodriguez, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. 2010–2697 Filed 2–5–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

Agency Information Collection 

Activities: Form I–129, Revision of an 

Existing Information Collection; 

Comment Request 

ACTION: 60-Day Notice of Information 

Collection Under Review: Form I–129, 

Petition for Nonimmigrant Worker; 

OMB Control Number 1615–0009. 

The Department of Homeland 

Security, U.S. Citizenship and 

Immigration Services has submitted the 

following information collection request 

for review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The information collection is 

published to obtain comments from the 

public and affected agencies. Comments 

are encouraged and will be accepted for 

60 days until April 9, 2010. 

Written comments and suggestions 

regarding items contained in this notice, 

and especially with regard to the 

estimated public burden and associated 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

Federal Register / Vol. 75, No. 25 / Monday, February 8, 2010 / Notices 6213 

response time should be directed to the 

Department of Homeland Security 

(DHS), USCIS, Chief, Regulatory 

Products Division, Clearance Office, 111 

Massachusetts Avenue, NW., Suite 

3008, Washington, DC 20529–2210. 

Comments may also be submitted to 

DHS via facsimile to 202–272–8352, or 

via e-mail at rfs.regs@dhs.gov. When 

submitting comments by e-mail please 

add the OMB Control Number 1615– 

0009 in the subject box. 

Written comments and suggestions 

from the public and affected agencies 

concerning the collection of information 

should address one or more of the 

following four points: 

(1) Evaluate whether the collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical utility; 

(2) Evaluate the accuracy of the 

agency’s estimate of the burden of the 

collection of information, including the 

validity of the methodology and 

assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Revision of a currently approved 

information collection. 

(2) Title of the Form/Collection: 

Petition for Nonimmigrant Worker. 

(3) Agency form number, if any and 

the applicable component of the 

Department of Homeland Security 

sponsoring the collection: Form I–129. 

U.S. Citizenship and Immigration 

Services. 

(4) Affected public who will be asked 

or required to respond, as well as brief 

abstract: Primary: Businesses. This form 

is used by an employer to petition for 

aliens to come to the U.S. temporarily 

to perform services, labor, and training 

or to request extensions of stay or 

changes in nonimmigrant status for 

nonimmigrant workers. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: 364,048 responses at 2.75 

hours per response; and 18,500 

(Religious Workers) at 3 hours per 

response. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: 1,056,632 annual burden 

hours. 

If you have additional comments, 

suggestions, or need a copy of the 

information collection instrument, 

please visit the Web site at: http:// 

www.regulations.gov. 

We may also be contacted at: USCIS, 

Regulatory Products Division, 111 

Massachusetts Avenue, NW., Suite 

3008, Washington, DC 20529–2210, 

telephone number 202–272–8377. 

Dated: February 3, 2010. 

Stephen Tarragon, 

Deputy Chief, Regulatory Products Division, 

U.S. Citizenship and Immigration Services, 

Department of Homeland Security. 

[FR Doc. 2010–2662 Filed 2–5–10; 8:45 am] 

BILLING CODE 9111–97–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID: FEMA–2009–0001] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request, OMB No. 

1660–0017; Public Assistance Program 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice; 30-day notice and 

request for comments; revision of a 

currently approved information 

collection; OMB No. 1660–0017; Public 

Assistance Program; FEMA Form 90–49, 

Request for Public Assistance; FEMA 

Form 90–91, Project Worksheet (PW); 

FEMA Form 90–91A, Project 

Worksheet—Damage Description and 

Scope of Work Continuation Sheet; 

FEMA Form 90–91B, Project 

Worksheet—Cost Estimate Continuation 

Sheet; FEMA Form 90–91C Project 

Worksheet—Maps and Sketches Sheet; 

FEMA Form 90–91D, Project 

Worksheet—Photo Sheet; FEMA Form 

90–120, Special Considerations 

Questions; FEMA Form 121, PNP 

Facility Questionnaire; FEMA Form 90– 

123, Force Account Labor Summary 

Record; FEMA Form 90–124, Materials 

Summary Record; FEMA Form 90–125, 

Rented Equipment Summary Record; 

FEMA Form 90–126, Contract Work 

Summary Record; FEMA Form 90–127, 

Force Account Equipment Summary 

Record; and FEMA Form 90–128, 

Applicant’s Benefits Calculation 

Worksheet. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) has 

submitted the information collection 

abstracted below to the Office of 

Management and Budget for review and 

clearance in accordance with the 

requirements of the Paperwork 

Reduction Act of 1995. The submission 

describes the nature of the information 

collection, the categories of 

respondents, the estimated burden (i.e., 

the time, effort and resources used by 

respondents to respond) and cost, and 

the actual data collection instruments 

FEMA will use. 

DATES: Comments must be submitted on 

or before March 10, 2010. 

ADDRESSES: Submit written comments 

on the proposed information collection 

to the Office of Information and 

Regulatory Affairs, Office of 

Management and Budget. Comments 

should be addressed to the Desk Officer 

for the Department of Homeland 

Security, Federal Emergency 

Management Agency, and sent via 

electronic mail to 

oira.submission@omb.eop.gov or faxed 

to (202) 395–5806. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information or 

copies of the information collection 

should be made to Director, Office of 

Records Management, 1800 South Bell 

Street, Arlington, VA 20598–3005, 

facsimile number (202) 646–3347, or email address FEMA-InformationCollections@dhs.gov. 

SUPPLEMENTARY INFORMATION: 

Collection of Information 

Title: Public Assistance Program. 

Type of information collection: 

Revision of a currently approved 

information collection. 

OMB Number: 1660–0017. 

Form Titles and Numbers: FEMA 

Form 90–49, Request for Public 

Assistance; FEMA Form 90–91, Project 

Worksheet (PW); FEMA Form 90–91A, 

Project Worksheet—Damage Description 

and Scope of Work Continuation Sheet; 

FEMA Form 90–91B, Project 

Worksheet—Cost Estimate Continuation 

Sheet; FEMA Form 90–91C Project 

Worksheet—Maps and Sketches Sheet; 

FEMA Form 90–91D, Project 

Worksheet—Photo Sheet; FEMA Form 

90–120, Special Considerations 

Questions; FEMA Form 121, PNP 

Facility Questionnaire; FEMA Form 90– 

123, Force Account Labor Summary 

Record; FEMA Form 90–124, Materials 

Summary Record; FEMA Form 90–125, 

Rented Equipment Summary Record; 

FEMA Form 90–126, Contract Work 

Summary Record; FEMA Form 90–127, 

Force Account Equipment Summary 

Record; and FEMA Form 90–128, 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES